Home›Companies›Biotech & Pharma›Biovantix Biotechnology

Biovantix Biotechnology, Inc

No website or LinkedIn page we could confirm. Why?
Updated Nov 17, 2026·Latest SEC filing Oct 17, 2025·Suggest an edit

About Biovantix Biotechnology

Biovantix Biotechnology is a private company based in Dover, Delaware, incorporated in 2025 in Delaware. It has reported $0 raised in two offerings on Form D since October 2025. Its chief executive is Christian Carnes.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Not yetOct 17, 2025$0of $15.0M target0—EquityRule 506(c)Form D ↗
Not yetOct 17, 2025$0of $15.0M target0—EquityRule 506(b)Form D ↗
Total, two offerings$0

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Biovantix Biotechnology's Form D filed Oct 17, 2025.

CC
Christian Carnes
Chief Executive Officer
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.
JS
Jack Sunier
COO
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.
EV
Elena Verutina
Chief People Officer
On every Form D that Biovantix Biotechnology has filed: 2 filings, from Oct 17, 2025 to Oct 17, 2025.

Sources

  1. SECBiovantix Biotechnology, Inc filing history